Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer

Ozgur E., Ferhatoglu F., Sen F., Saip P., Gezer U.

CANCER BIOMARKERS, cilt.27, sa.1, ss.11-17, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3233/cbm-190085
  • Dergi Adı: CANCER BIOMARKERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.11-17
  • Anahtar Kelimeler: Breast cancer, neoadjuvant chemotherapy, pathological complete response, long non-coding RNAs, blood plasma, NONCODING RNA H19, THERAPY, PLASMA, TUMOR
  • İstanbul Üniversitesi Adresli: Evet

Özet

BACKGROUND: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC).